AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36002801 — intervention group
Group type: EXPERIMENTAL
Intervention: Theoretical Domains Framework (TDF) analysis
Number of subjects: 25
Study 36002801 — intervention group
Group type: EXPERIMENTAL
Intervention: Thematic analysis of belief statements
Number of subjects: 25
Study 33883291 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent supervised and unsupervised training program focusing on muscle power (5 weeks supervised, 6 weeks unsupervised)
Number of subjects: 35
Study 33883291 — intervention group
Group type: COMPARATOR
Intervention: Control group (robust)
Number of subjects: 35
Study 33883291 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent supervised and unsupervised training program focusing on muscle power
Number of subjects: 35
Study 36479062 — intervention group
Group type: EXPERIMENTAL
Intervention: AmeriCorps Seniors volunteering program
Number of subjects: 300
Study 36479062 — intervention group
Group type: COMPARATOR
Intervention: Active control (self-guided life review)
Number of subjects: 300
Study 33448933 — intervention group
Group type: EXPERIMENTAL
Intervention: VRelax
Number of subjects: 50
Study 33448933 — intervention group
Group type: COMPARATOR
Intervention: Standard relaxation
Number of subjects: 50
Study 36109816 — intervention group
Group type: EXPERIMENTAL
Intervention: Mask promotion intervention
Number of subjects: 0
Study 36109816 — intervention group
Group type: EXPERIMENTAL
Intervention: Unblinded and supposedly blinded steps
Number of subjects: 0
Study 34932440 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care intervention
Number of subjects: 635
Study 34932440 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 635
Study 34932440 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 635
Study 36931429 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery with endoscopic cyclophotocoagulation (ECP)
Number of subjects: 160
Study 36931429 — intervention group
Group type: COMPARATOR
Intervention: Cataract surgery alone
Number of subjects: 160
Study 32643311 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (FIO2 0.12)
Number of subjects: 12
Study 32643311 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (FIO2 0.145)
Number of subjects: 12
Study 32643311 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (FIO2 0.17)
Number of subjects: 12
Study 32643311 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (FIO2 0.2093)
Number of subjects: 12
Study 33044990 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco Cessation on Prescription (TCP)
Number of subjects: 8
Study 33044990 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized counseling from a tobacco cessation specialist
Number of subjects: 8
Study 33044990 — intervention group
Group type: EXPERIMENTAL
Intervention: Empathetic approach in treatment and long-term follow-up
Number of subjects: 8
Study 33044990 — intervention group
Group type: EXPERIMENTAL
Intervention: Holistic approach combined with interventions outside the health care system
Number of subjects: 8
Study 35198926 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus moxibustion (3 sessions per week for 12 weeks)
Number of subjects: 66
Study 35198926 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus moxibustion
Number of subjects: 66
Study 35198926 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 66
Study 32589775 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir (RDV) 75 mg or 150 mg lyophilized formulation infused over 30 minutes or 2 hours
Number of subjects: 0
Study 32589775 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir (RDV) 150 mg once daily for 7 or 14 days
Number of subjects: 0
Study 32589775 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir (RDV) single-dose i.v. administration over 2 hours (dose range 3-225 mg)
Number of subjects: 0
Study 32589775 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir (RDV) solution and lyophilized formulations
Number of subjects: 0
Study 33809922 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 60
Study 32028398 — intervention group
Group type: EXPERIMENTAL
Intervention: Tecfidera (dimethyl fumarate)
Number of subjects: 0
Study 32028398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35458231 — intervention group
Group type: EXPERIMENTAL
Intervention: High fiber rye foods
Number of subjects: 0
Study 35458231 — intervention group
Group type: COMPARATOR
Intervention: Refined wheat foods
Number of subjects: 0
Study 34111765 — intervention group
Group type: EXPERIMENTAL
Intervention: OUES2min
Number of subjects: 21
Study 34111765 — intervention group
Group type: EXPERIMENTAL
Intervention: OUES3min
Number of subjects: 21
Study 34111765 — intervention group
Group type: EXPERIMENTAL
Intervention: OUES4min
Number of subjects: 21
Study 34111765 — intervention group
Group type: EXPERIMENTAL
Intervention: CPET-measured VO2peak
Number of subjects: 21
Study 32245717 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video about the role and responsibilities of medical students, residents, and attending surgeons.
Number of subjects: 140
Study 32245717 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational video).
Number of subjects: 140
Study 34126510 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-based ion-leaching materials (RB-ILMs)
Number of subjects: 15
Study 34126510 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-modified glass-ionomer cements (RMGICs)
Number of subjects: 15
Study 34126510 — intervention group
Group type: EXPERIMENTAL
Intervention: High-viscosity glass-ionomer cements (HVGICs)
Number of subjects: 15
Study 34126510 — intervention group
Group type: EXPERIMENTAL
Intervention: Biaxial flexural strength (B-FS)
Number of subjects: 15
Study 34126510 — intervention group
Group type: EXPERIMENTAL
Intervention: Porosity analysis using ImageJ software
Number of subjects: 15
Study 34126510 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexural modulus (4 PB-E) and flexural toughness (4 PB-T)
Number of subjects: 15
Study 32078256 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day regimen (35-50 IU/kg)
Number of subjects: 59
Study 32078256 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day regimen (50-75 IU/kg)
Number of subjects: 59
Study 32078256 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-day regimen (50-75 IU/kg)
Number of subjects: 59
Study 32078256 — intervention group
Group type: EXPERIMENTAL
Intervention: 21-day regimen (100 IU/kg)
Number of subjects: 59
Study 32078256 — intervention group
Group type: COMPARATOR
Intervention: 14-day regimen
Number of subjects: 59
Study 32078256 — intervention group
Group type: COMPARATOR
Intervention: 21-day regimen
Number of subjects: 59
Study 32078256 — intervention group
Group type: EXPERIMENTAL
Intervention: rIX-FP infusions
Number of subjects: 59
Study 32078256 — intervention group
Group type: EXPERIMENTAL
Intervention: rIX-FP
Number of subjects: 59
Study 35431237 — intervention group
Group type: EXPERIMENTAL
Intervention: Glargine allocation
Number of subjects: 8365
Study 35431237 — intervention group
Group type: COMPARATOR
Intervention: Clinical risk factors
Number of subjects: 8365
Study 33712532 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F-florbetaben visual rating protocol
Number of subjects: 7
Study 33712532 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F-florbetapir visual rating protocol
Number of subjects: 7
Study 33712532 — intervention group
Group type: COMPARATOR
Intervention: All 3 approved visual rating protocols
Number of subjects: 7
Study 32322023 — intervention group
Group type: EXPERIMENTAL
Intervention: 30:2 compression-to-ventilation ratio
Number of subjects: 26
Study 32322023 — intervention group
Group type: COMPARATOR
Intervention: 15:2 compression-to-ventilation ratio
Number of subjects: 26
Study 32322023 — intervention group
Group type: EXPERIMENTAL
Intervention: Both 30:2 and 15:2 ratios
Number of subjects: 26
Study 36068186 — intervention group
Group type: EXPERIMENTAL
Intervention: Color Doppler ultrasound guided cannulation
Number of subjects: 40
Study 36068186 — intervention group
Group type: COMPARATOR
Intervention: Blind cannulation method
Number of subjects: 40
Study 32567290 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of vitamin A and D supplementation
Number of subjects: 120
Study 32567290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 32567290 — intervention group
Group type: COMPARATOR
Intervention: Vitamin A only
Number of subjects: 120
Study 32567290 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D only
Number of subjects: 120
Study 36064177 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training through a mobile application (En Calma en el Quirófano)
Number of subjects: 82
Study 36064177 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 82
Study 33518325 — intervention group
Group type: EXPERIMENTAL
Intervention: PFA-C 250 ppm
Number of subjects: 600
Study 33518325 — intervention group
Group type: EXPERIMENTAL
Intervention: PFA-C 400 ppm
Number of subjects: 600
Study 33518325 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 600
Study 32475359 — intervention group
Group type: EXPERIMENTAL
Intervention: Fragmented + Coffee (300 mg caffeine)
Number of subjects: 29
Study 32475359 — intervention group
Group type: COMPARATOR
Intervention: Fragmented (waking hourly for 5 min)
Number of subjects: 29
Study 32475359 — intervention group
Group type: COMPARATOR
Intervention: Control (habitual night of sleep)
Number of subjects: 29
Study 34878707 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 2 mg/kg
Number of subjects: 288
Study 34878707 — intervention group
Group type: COMPARATOR
Intervention: Neostigmine 50 µg/kg
Number of subjects: 288
Study 34878707 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 4 mg/kg
Number of subjects: 288
Study 34389022 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-selected music
Number of subjects: 174
Study 34389022 — intervention group
Group type: COMPARATOR
Intervention: Predetermined music (MUSIC CARE® application)
Number of subjects: 174
Study 34205744 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth application-based lifestyle coaching program
Number of subjects: 170
Study 32086893 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile platform SCIT management
Number of subjects: 86
Study 32086893 — intervention group
Group type: COMPARATOR
Intervention: Conventional SCIT management
Number of subjects: 86
Study 33166731 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoarthritis
Number of subjects: 320136
Study 32534628 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvanted AGS-v vaccine (200 nmol with Montanide ISA 51)
Number of subjects: 49
Study 32534628 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine only AGS-v (200 nmol)
Number of subjects: 49
Study 32534628 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sterile water)
Number of subjects: 49
Study 36376023 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone (IVMP) pulse for 3 months
Number of subjects: 80
Study 36376023 — intervention group
Group type: COMPARATOR
Intervention: Antiseizure medication (ASM) only
Number of subjects: 80
Study 32192954 — intervention group
Group type: EXPERIMENTAL
Intervention: Low cost intervention (paying 1/3 unit deducts 1 unit of the allocator in Experiment 1)
Number of subjects: 157
Study 32192954 — intervention group
Group type: EXPERIMENTAL
Intervention: High cost intervention (paying 1 unit deducts 1 unit of the allocator in Experiment 2)
Number of subjects: 157
Study 34404273 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief motivational intervention with a booster
Number of subjects: 596
Study 34404273 — intervention group
Group type: COMPARATOR
Intervention: Control group (other brief alcohol interventions)
Number of subjects: 596
Study 33986051 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretch training on the 'five-Business' device, 22-24 training units of 10 minutes each, two times a week for 12 weeks.
Number of subjects: 252
Study 33986051 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretch training on the 'five-Business' device
Number of subjects: 252
Study 34030214 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI) in addition to care-as-usual (CAU)
Number of subjects: 103
Study 34030214 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual (CAU)
Number of subjects: 103
Study 36171019 — intervention group
Group type: COMPARATOR
Intervention: Ixekizumab
Number of subjects: 0
Study 36171019 — intervention group
Group type: COMPARATOR
Intervention: mCPDAI
Number of subjects: 0
Study 36171019 — intervention group
Group type: COMPARATOR
Intervention: DAPSA
Number of subjects: 0
Study 36171019 — intervention group
Group type: COMPARATOR
Intervention: mCPDAI and DAPSA
Number of subjects: 0
Study 36171019 — intervention group
Group type: COMPARATOR
Intervention: All composites
Number of subjects: 0
Study 36171019 — intervention group
Group type: COMPARATOR
Intervention: MDA/VLDA
Number of subjects: 0
Study 36171019 — intervention group
Group type: COMPARATOR
Intervention: LDA
Number of subjects: 0
Study 32367738 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (vitamin D3) added to myo-inositol, alpha-lactalbumin, and folic acid in the evening from the early beginning of the luteal phase.
Number of subjects: 120
Study 32367738 — intervention group
Group type: COMPARATOR
Intervention: Myo-inositol, alpha-lactalbumin, and folic acid in the morning, and myo-inositol, folic acid and melatonin in the evening.
Number of subjects: 120
Study 32176866 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (50 mg)
Number of subjects: 27
Study 32176866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 32199926 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine prescription of 28 tablets of oxycodone 5 mg
Number of subjects: 118
Study 32199926 — intervention group
Group type: COMPARATOR
Intervention: Reduced prescription of 5 tablets of oxycodone 5 mg
Number of subjects: 118
Study 36396066 — intervention group
Group type: EXPERIMENTAL
Intervention: Core intervention (booklet and personal report) + text messaging (on/off) + self-monitoring modality (digital/paper) + health coaching (on/off) + support person coaching (on/off)
Number of subjects: 400
Study 33137600 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Processing Therapy (CPT) alone
Number of subjects: 52
Study 33137600 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT) then Behavioural Activation Therapy (BA) for MDD
Number of subjects: 52
Study 33137600 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural Activation Therapy (BA) then Cognitive Processing Therapy (CPT)
Number of subjects: 52
Study 35766588 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (diode laser 940 nm, 31.7 J/cm2 energy density, 1.7 cm2 spot size, 300 mW power, continuous-wave, contact mode)
Number of subjects: 28
Study 35766588 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft acrylic wafer
Number of subjects: 28
Study 35766588 — intervention group
Group type: COMPARATOR
Intervention: Laser in off mode (placebo)
Number of subjects: 28
Study 35766588 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 28
Study 32918555 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow stimulation (BMS)
Number of subjects: 60
Study 32366992 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical rifampicin irrigation
Number of subjects: 517
Study 32366992 — intervention group
Group type: COMPARATOR
Intervention: Historical cohort (control)
Number of subjects: 517
Study 32366992 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical rifampicin
Number of subjects: 517
Study 36384542 — intervention group
Group type: EXPERIMENTAL
Intervention: FPCR-BL (Flipped Physical Classroom Blended Learning)
Number of subjects: 328
Study 36384542 — intervention group
Group type: EXPERIMENTAL
Intervention: FVCR-BL (Flipped Virtual Classroom Blended Learning)
Number of subjects: 328
Study 36384542 — intervention group
Group type: COMPARATOR
Intervention: PCR-TL (Traditional Learning Model in Physical Classroom)
Number of subjects: 328
Study 36384542 — intervention group
Group type: EXPERIMENTAL
Intervention: FPCR-BL
Number of subjects: 328
Study 36384542 — intervention group
Group type: EXPERIMENTAL
Intervention: Online learning
Number of subjects: 328
Study 34113680 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-centered social cognitive factors intervention
Number of subjects: 240
Study 32012251 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat/calorie meal
Number of subjects: 29
Study 32012251 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat/calorie meal
Number of subjects: 29
Study 32012251 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole milk
Number of subjects: 29
Study 32012251 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 29
Study 32012251 — intervention group
Group type: COMPARATOR
Intervention: Fasted state
Number of subjects: 29
Study 35139574 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH antagonist administration the day after hCG triggering
Number of subjects: 267
Study 35139574 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment regime
Number of subjects: 267
Study 34382648 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-messaging intervention providing educational information and links to videos
Number of subjects: 140
Study 34382648 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-messaging intervention
Number of subjects: 140
Study 34382648 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 140
Study 32470531 — intervention group
Group type: EXPERIMENTAL
Intervention: EMI group
Number of subjects: 7860
Study 32470531 — intervention group
Group type: EXPERIMENTAL
Intervention: PIS group
Number of subjects: 7860
Study 32470531 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombectomy group with EMI
Number of subjects: 7860
Study 32470531 — intervention group
Group type: COMPARATOR
Intervention: PCI alone group with EMI
Number of subjects: 7860
Study 32470531 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombectomy group with PIS
Number of subjects: 7860
Study 32470531 — intervention group
Group type: COMPARATOR
Intervention: PCI alone group with PIS
Number of subjects: 7860
Study 34474432 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam Rolling
Number of subjects: 16
Study 34474432 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration Foam Rolling
Number of subjects: 16
Study 33487517 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical implementation strategy (all units trained simultaneously)
Number of subjects: 0
Study 33487517 — intervention group
Group type: COMPARATOR
Intervention: Horizontal implementation strategy (one lead-off unit trained first)
Number of subjects: 0
Study 33487517 — intervention group
Group type: EXPERIMENTAL
Intervention: Both implementation strategies
Number of subjects: 0
Study 33216113 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized PC786 (5 mg)
Number of subjects: 56
Study 33216113 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 32757038 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhino-Protect ointment
Number of subjects: 93
Study 33189894 — intervention group
Group type: EXPERIMENTAL
Intervention: HI group performed 10 standing headers
Number of subjects: 3
Study 33189894 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg impact group performed 10 soccer ball trapping maneuvers over 10 min
Number of subjects: 3
Study 33189894 — intervention group
Group type: COMPARATOR
Intervention: Control group did not participate in any soccer drills
Number of subjects: 3
Study 33371086 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous nursing treatment scheme based on Omaha system (OS)
Number of subjects: 200
Study 33371086 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment including general guidance associated with PD and outpatient telephone calls from clinical nurses
Number of subjects: 200
Study 35590298 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnification loupes (2.5×)
Number of subjects: 59
Study 35590298 — intervention group
Group type: COMPARATOR
Intervention: Participants with high visual acuity
Number of subjects: 59
Study 33084903 — intervention group
Group type: EXPERIMENTAL
Intervention: Gutka usage (smokeless tobacco)
Number of subjects: 0
Study 32160926 — intervention group
Group type: EXPERIMENTAL
Intervention: Met/Cys-low diet (n=7)
Number of subjects: 20
Study 32160926 — intervention group
Group type: COMPARATOR
Intervention: Met/Cys-high diet (n=6)
Number of subjects: 20
Study 32160926 — intervention group
Group type: EXPERIMENTAL
Intervention: Met/Cys-medium diet (n=7)
Number of subjects: 20
Study 33839178 — intervention group
Group type: EXPERIMENTAL
Intervention: Lightwand
Number of subjects: 200
Study 33839178 — intervention group
Group type: COMPARATOR
Intervention: Fiberoptic bronchoscope
Number of subjects: 200
Study 33839178 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 200
Study 33839178 — intervention group
Group type: COMPARATOR
Intervention: Glidescope
Number of subjects: 200
Study 32537072 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 281
Study 32537072 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine (ASAQ)
Number of subjects: 281
Study 35511958 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease Intervention Specialists (DIS) intervention for re-engagement in care
Number of subjects: 2958
Study 35511958 — intervention group
Group type: COMPARATOR
Intervention: Non-randomized patients
Number of subjects: 2958
Study 33554783 — intervention group
Group type: EXPERIMENTAL
Intervention: Run‐Hide‐Fight® video
Number of subjects: 0
Study 33554783 — intervention group
Group type: COMPARATOR
Intervention: Control group (not exposed to the video)
Number of subjects: 0
Study 32243207 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib 150 mg twice daily
Number of subjects: 70
Study 32243207 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 32243207 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 70
Study 35241538 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (40 mg/m2)
Number of subjects: 150
Study 35241538 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin AUC2 and Paclitaxel (45 mg/m2)
Number of subjects: 150